Literature DB >> 26362397

CF healthcare workers feel unprepared in providing suitable end of life care and desire more education: Results of a nationwide survey.

Jessica Goggin1, Rubin I Cohen2.   

Abstract

INTRODUCTION: Little is known about the depth of knowledge and preparedness of CF caregivers in delivering end of life and palliative care to CF patients and families.
METHOD: Nationwide survey questionnaires for CF care providers using the CF Foundation Listserv electronic web-based tool.
RESULTS: The majority of non-physician CF care providers (55%) had more than 15 years of experience in their discipline and 84% of physician had greater than 15 years of experience. The majority reported that they felt "somewhat" or "very" involved in palliative or end of life care in their current role. Yet, when asked whether they felt adequately prepared to deliver palliative and end of life care, only 18% reported that they were "fully prepared" and 45% felt that they were only "minimally" or "not" prepared. Further, only one third of respondents received more than 10h of education in general palliative or end-of-life care, while only 10% had received more than 10h of education specific to CF end of life care. The majority (73%) of CF healthcare providers preferred more education specific to CF end of life care.
CONCLUSION: CF healthcare providers are involved in CF end of life issues but a fair number did not understand their role and felt inadequately prepared in delivering suitable end of life and palliative care. Many desired more education in the provision of such care.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CF care providers; Education; End of life care; Palliative care; Survey

Mesh:

Year:  2015        PMID: 26362397     DOI: 10.1016/j.jcf.2015.08.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

1.  Palliative Care Needs of Individuals with Cystic Fibrosis: Perspectives of Multiple Stakeholders.

Authors:  Elisabeth P Dellon; Melissa Basile; Mara R Hobler; Anna M Georgiopoulos; Elaine Chen; Jessica Goggin; Christopher H Goss; Sarah E Hempstead; Albert Faro; Dio Kavalieratos
Journal:  J Palliat Med       Date:  2020-02-05       Impact factor: 2.947

2.  Palliative drug treatments for breathlessness in cystic fibrosis.

Authors:  Nishant Jaiswal; Meenu Singh; Amit Agarwal; Anil Chauhan; Nikita Jaiswal
Journal:  Cochrane Database Syst Rev       Date:  2020-04-28

3.  What Does the Staff Think?: Factors Associated With Clinical Staff Perceptions of What Constitutes High-Quality Dying and Death at a Tertiary Pediatric Hospital.

Authors:  Rebecca Bennett; James Proudfoot
Journal:  J Hosp Palliat Nurs       Date:  2016-10       Impact factor: 1.918

Review 4.  Palliative drug treatments for breathlessness in cystic fibrosis.

Authors:  Nishant Jaiswal; Meenu Singh; Amit Agarwal; Kiran K Thumburu
Journal:  Cochrane Database Syst Rev       Date:  2017-08-10

5.  Highlights from the 2015 North American Cystic Fibrosis Conference.

Authors:  Edith T Zemanick; Thida Ong; Cori L Daines; Elisabeth P Dellon; Marianne S Muhlebach; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2016-04-13

6.  Assessing Practices, Beliefs, and Attitudes about Palliative Care among People with Cystic Fibrosis, Their Caregivers, and Clinicians: Results of a Content Analysis.

Authors:  Melissa Basile; Lincy Jojan; Mara R Hobler; Elisabeth P Dellon; Anna M Georgiopoulos; Jessica L Goggin; Elaine Chen; Christopher H Goss; Sarah E Hempstead; Albert Faro; Dio Kavalieratos
Journal:  J Palliat Med       Date:  2021-04-20       Impact factor: 2.947

7.  Improving end-of-life care for adults with cystic fibrosis: an improvement project.

Authors:  Fiona Cathcart; Jayne Wood; Su Madge
Journal:  BMJ Open Qual       Date:  2020-08

8.  Models of Palliative Care Delivery for Individuals with Cystic Fibrosis: Cystic Fibrosis Foundation Evidence-Informed Consensus Guidelines.

Authors:  Dio Kavalieratos; Anna M Georgiopoulos; Lara Dhingra; Melissa J Basile; Elliot Rabinowitz; Sarah E Hempstead; Albert Faro; Elisabeth P Dellon
Journal:  J Palliat Med       Date:  2020-09-16       Impact factor: 2.947

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.